14th ICID - Poster Abstracts - International Society for Infectious ...
14th ICID - Poster Abstracts - International Society for Infectious ...
14th ICID - Poster Abstracts - International Society for Infectious ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
When citing these abstracts please use the following reference:<br />
Author(s) of abstract. Title of abstract [abstract]. Int J Infect Dis 2010;14S1: Abstract number.<br />
Please note that the official publication of the <strong>International</strong> Journal of <strong>Infectious</strong> Diseases 2010, Volume 14, Supplement 1<br />
is available electronically on http://www.sciencedirect.com<br />
Final Abstract Number: 28.029<br />
Session: Influenza<br />
Date: Wednesday, March 10, 2010<br />
Time: 12:30-13:30<br />
Room: <strong>Poster</strong> & Exhibition Area/Ground Level<br />
Type: <strong>Poster</strong> Presentation<br />
H1N1 Epidemic: Our experience at PGIMER Delhi, India<br />
A. yadav, T. samra, M. pawar<br />
Dr.RML Hospital,PGIMER , New Delhi, India<br />
Background: Patients infected with the H1N1 strain of the influenza A virus frequently develop<br />
rapidly progressive lower respiratory tract disease resulting in respiratory failure. We describe the<br />
clinical characteristics of patients who expired in ICU at our hospital in Delhi, India. We did the<br />
study to see cause and pattern of death in H1N1.<br />
Methods: Using guidelines developed by the Indian health ministry, all individuals with flu-like<br />
symptoms were screened by a physician into three management categories- Category A (outpatient<br />
treatment and home isolation), Category B (hospital isolation ward) and Category C<br />
(intensive care units) based on clinical presentation. Of the 236 patients with confirmed H1N1<br />
evaluated between 8th August to 27th October 2009 at our facility, 26 patients expired. Data was<br />
collected from the hospital records <strong>for</strong> patients with H1N1, who expired in the ICU. Influenza A<br />
(H1N1) virus infection was confirmed in specimens using TaqMan real-time reverse transcriptasepolymerase-chain-reaction<br />
(CDC Protocol).<br />
Results: Median age was 29 years (Range: 12 - 74); >80% of patients were < 40 years. Three<br />
(11.5%) were diabetic, 2 (7. 7%) pregnant, 5(19.2%) hypertensive, 2(7. 7%) had pre-existing<br />
respiratory disease and 14 (53.9%) had no pre-existing medical conditions. 24 (92.3%) had<br />
primary viral pneumonitis and 2 (7.7%) had exacerbation of structural respiratory disease. 14<br />
(53.9%) developed acute respiratory distress syndrome (ARDS), 4(15.4%) developed multi organ<br />
dysfunction syndrome (MODS), 3 (11.5%) developed acute renal failure (ARF), 2(7.7%)<br />
developed myocarditis/Congestive heart failure (CHF) and 3(11.5%) developed disseminated<br />
intravascular coagulopathy (DIC).All 26 required mechanical ventilation. Oseltamivir<br />
administration delay ranged from 3 to 10 days after illness onset, 52.78% received high-dose<br />
(300mg/day) treatment, and treatment duration ranged from 1 to 10 days (mean 3.0 ± 2.5days).<br />
Conclusion: Over a 12 week period, H1N1 virus infection caused ICU deaths in 26 adult patients<br />
with a high case fatality rate of 26/236 (11.0%). Deaths resulted from organ failures including<br />
ARDS, MODS, ARF, DIC and CHF. Clinicians should be aware of the severe organ complications<br />
of H1N1, particularly in pregnant and previously healthy young adults